Injectable Lidocaine Recalled Due to Lack of Sterility Assurance
Central Admixture Pharmacy Services is recalling lidocaine 2% injectables due to inability to assure sterility. Approximately 1,992 syringes distributed nationwide are affected.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable medication where the manufacturer cannot assure sterility. While no illnesses or injuries have been reported, this represents a risk-of-harm product where sterile manufacturing integrity is compromised.
Plain-English summary
Central Admixture Pharmacy Services Inc is recalling lidocaine 2% (100 mg/5 mL) injectable syringes due to a lack of assurance of sterility. The recall affects approximately 1,992 syringes distributed nationwide.
The recalled product is lidocaine 2%, 20 mg/mL supplied in 5 mL syringes, manufactured by Central Admixture Pharmacy Services Inc (NDC 71286-6006-1). The affected lots are 17-275788 (expiring 10/10/2023), 17-275872 (expiring 10/11/2023), 17-275922 (expiring 10/12/2023), and 17-275972 and 17-275973 (both expiring 10/15/2023).
Sterile injectable medications must maintain sterility to prevent harm. The manufacturer was unable to provide assurance that these lots met sterility requirements.
Persons who have received or are using this product should discontinue use and contact the manufacturer or the FDA for guidance on return or disposal of unused product.
The recalled product
- Product
- lidocaine 2%, 100 mg/5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6006-1
- Manufacturer
- Central Admixture Pharmacy Services Inc
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot: 17-275788
- Exp. 10/10/2023
- 17-275872
- Exp. 10/11/2023
- 17-275922
- Exp. 10/12/2023
- 17-275972
- 17-275973
- Exp. 10/15/2023.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 32 recalled by Central Admixture Pharmacy Services Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 32 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services Inc
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighFentanyl injectable syringes recalled nationwide for sterility assurance failure
FDA (Drugs) · 2023-10-11
- HighHYDROmorphone Injectable Syringes Recalled Over Sterility Assurance Issues
FDA (Drugs) · 2023-10-11
Same hazard · contamination risk
See all →- ModerateAVID Medical Recalls Halyard IV Start Kits Due to Packaging Seal Issues
FDA (Devices) · 2026-09-30
- SevereBaxter Recalls Vancomycin Injection Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighIntramedullary Bone Saw Blade Assembly Recall for Packaging Damage
FDA (Devices) · 2026-08-12
Similar recalls
- HighLidocaine Injectable Syringes Recalled for Sterilization Assurance Concerns
FDA (Drugs) · 2023-08-09
- HighLidocaine Injectable Solution Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2023-05-31
- HighKetamine Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-08-09
- HighFentanyl Injectable Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-08-09
- HighePHEDrine Injectable Syringes Recalled Over Sterility Assurance Gaps
FDA (Drugs) · 2023-08-09
- HighMorphine Injectable Syringes Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-08-09